|Bid||902.70 x 0|
|Ask||903.20 x 0|
|Day's Range||893.30 - 906.00|
|52 Week Range||707.00 - 1,084.80|
|Beta (5Y Monthly)||0.30|
|PE Ratio (TTM)||475.26|
|Forward Dividend & Yield||25.94 (2.88%)|
|Ex-Dividend Date||Aug 13, 2020|
|1y Target Est||93.83|
Dr. Hilary Babcock, Professor of Medicine in the Infectious Diseases division at Washington University School of Medicine joins Yahoo Finance's Kristin Myers to discuss the latest coronavirus developments as U.S. hospitalizations reach an all time high.
Britain on Wednesday became the first Western country to approve a COVID-19 vaccine, jumping ahead of the United States and Europe after its regulator cleared a shot developed by Pfizer and BioNTech for emergency use in record time. Pfizer, with partner BioNTech SE, and rival Moderna have released trial data showing their COVID-19 vaccines to be about 95% effective at preventing the illness, while AstraZeneca last month said its vaccine was on average about 70% effective.
'No, I never considered it was risky, and no, of course, I’m not getting paid. I just received my second shot a few days ago,' writes Pierre Briançon of volunteering for a vaccine trial in London.